Unknown

Dataset Information

0

Genetic Variation in CCL18 Gene Influences CCL18 Expression and Correlates with Survival in Idiopathic Pulmonary Fibrosis-Part B.


ABSTRACT: Idiopathic pulmonary fibrosis (IPF) is a progressive disease with high mortality. CC-chemokine ligand 18 (CCL18) is predictive of survival in IPF. We described correlation of CCL18 serum levels with the genotype of rs2015086 C > T polymorphism the CCL18-gene, which was associated with survival in a pre-antifibrotic cohort (Part-A). Herein (Part-B), we aimed to validate these findings and to study the effects of antifibrotics. Two cohorts were prospectively recruited, cohort-A (n = 61, pre-antifibrotic) and cohort B (n = 101, received antifibrotics). Baseline CCL18 serum level measurement by enzyme-linked immunosorbent assay (ELISA, serially in cohort B) and genotyping of rs2015086 was performed and correlated with clinical outcomes. The CT genotype was present in 15% and 31% of patients. These patients had higher CCL18 levels compared to the TT-genotype (cohort-A: 234 vs. 115.8 ng/mL, p < 0.001; cohort B: 159.5 vs. 120 ng/mL, p = 0.0001). During antifibrotic therapy, CCL18 increased (p = 0.0036) regardless of rs2015086-genotype and antifibrotic-agent. In cohort-A, baseline CCL18-cutoff (>120 ng/mL) and CT-genotype were associated with mortality (p = 0.041 and p = 0.0051). In cohort-B, the CCL18-cutoff (>140 ng/mL) was associated with mortality (p = 0.003) and progression (p = 0.004), but not the CT/CC-genotype. In conclusion, we validated the correlation between rs2015086-genotype and CCL18 serum levels, which was predictive of (progression-free)-survival in two prospective validation cohorts.

SUBMITTER: Caliskan C 

PROVIDER: S-EPMC7356861 | biostudies-literature | 2020 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

Genetic Variation in CCL18 Gene Influences CCL18 Expression and Correlates with Survival in Idiopathic Pulmonary Fibrosis-Part B.

Caliskan Canay C   Seeliger Benjamin B   Jäger Benedikt B   Fuge Jan J   Welte Tobias T   Terwolbeck Oliver O   Freise Julia J   van Moorsel Coline H M CHM   Zhang Yingze Y   Prasse Antje A  

Journal of clinical medicine 20200625 6


Idiopathic pulmonary fibrosis (IPF) is a progressive disease with high mortality. CC-chemokine ligand 18 (CCL18) is predictive of survival in IPF. We described correlation of CCL18 serum levels with the genotype of <i>rs2015086</i> C > T polymorphism the <i>CCL18</i>-gene, which was associated with survival in a pre-antifibrotic cohort (Part-A). Herein (Part-B), we aimed to validate these findings and to study the effects of antifibrotics. Two cohorts were prospectively recruited, cohort-A (<i>n  ...[more]

Similar Datasets

| S-EPMC7356165 | biostudies-literature
| S-EPMC4849867 | biostudies-literature
| S-EPMC5216513 | biostudies-literature
| S-EPMC8054271 | biostudies-literature
2022-07-01 | GSE175459 | GEO
2023-01-01 | GSE195770 | GEO
| PRJNA802122 | ENA
| S-EPMC10854325 | biostudies-literature
| S-EPMC10952500 | biostudies-literature
| S-EPMC9677133 | biostudies-literature